First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Hits New 52-Week High at $169.67

Shares of First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) hit a new 52-week high during trading on Monday . The company traded as high as $169.67 and last traded at $169.67, with a volume of 3416 shares traded. The stock had previously closed at $167.62.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

The business’s 50 day simple moving average is $159.69 and its 200 day simple moving average is $153.66. The company has a market capitalization of $1.30 billion, a PE ratio of 17.20 and a beta of 0.86.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. International Assets Investment Management LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 44,064.6% in the 4th quarter. International Assets Investment Management LLC now owns 184,608 shares of the company’s stock valued at $29,179,000 after acquiring an additional 184,190 shares during the period. Raymond James Financial Services Advisors Inc. raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 2.2% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 121,974 shares of the company’s stock valued at $18,783,000 after acquiring an additional 2,629 shares during the period. Berger Financial Group Inc raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 6.9% in the 4th quarter. Berger Financial Group Inc now owns 121,866 shares of the company’s stock valued at $19,262,000 after acquiring an additional 7,888 shares during the period. Ameritas Advisory Services LLC raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 3.8% in the 2nd quarter. Ameritas Advisory Services LLC now owns 50,431 shares of the company’s stock valued at $7,766,000 after acquiring an additional 1,828 shares during the period. Finally, Csenge Advisory Group raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 142.6% in the 2nd quarter. Csenge Advisory Group now owns 45,427 shares of the company’s stock valued at $6,995,000 after acquiring an additional 26,703 shares during the period.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.